Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Recent News

Wednesday 16 September, 2015

16-Sep-2015 01:00 PM

Boussard & Gavaudan NAV update

Boussard & Gavaudan says the estimated net asset value of its sterling shares was £17.2075 at the close of business on 15 September. The estimated NAV of its euro shares was �?¬19.5409. At 1:00pm: (LON:BGHS) Boussard Gavaudan Holding share price
16-Sep-2015 01:00 PM

Market Movers - Top risers and fallers at 13:00

FTSE 100 SABMiller 3633.75 +20.54% Aberdeen Asset Management 335.65 +4.79% Reckitt Benckiser Group 5868.00 +3.15% Hargreaves Lansdown 1218.50 +2.
16-Sep-2015 12:52 PM

Brokers' round-up, sell Inmarsat and Mondi

Berenberg cuts Inmarsat to sell from hold, target cut from 900p to 870p. Goldman Sachs cuts Mondi to sell from neutral, target cut from 1380p to 1300p. JP Morgan Cazenove cuts Rightmove to neutral from overweight, target raised from 2850p to 3850p. JP
16-Sep-2015 12:20 PM

Science Group acquires business and assets of Leatherhead

Science Group (AIM:SAG) has acquired the operating business and assets, excluding the freehold property, of Leatherhead Food International, a technical consultancy providing scientific research, regulatory advice, market insights, testing and other servic
16-Sep-2015 12:14 PM

Cynthia Carroll joins Vedanta

Vedanta Resources has announced that Cynthia Carroll is joining the Group as the chair of Vedanta Resources Holdings. In this role, Ms. Carroll will advise on key strategic initiatives for the chairman's office of Vedanta Resources, including corpo
16-Sep-2015 12:02 PM

Market Movers - Top risers and fallers between 11:00 and 12:00

Overall Market Cambridge Cognition Holdings 79.50 +1.92% Everyman Media Group 100.00 +1.52% Monitise 3.05 +0.66% Paragon Diamonds 5.21
16-Sep-2015 12:00 PM

Market Movers - Top risers and fallers at 12:00

FTSE 100 SABMiller 3620.00 +20.09% Aberdeen Asset Management 330.85 +3.29% Reckitt Benckiser Group 5834.00 +2.55% Hargreaves Lansdown 1217.00 +2.
16-Sep-2015 11:02 AM

Market Movers - Top risers and fallers between 10:00 and 11:00

Overall Market Copper Development Corporation 2.30 +7.98% Evraz 70.85 +0.45% Card Factory 364.75 +0.34% Monitise 3.05
16-Sep-2015 11:00 AM

Market Movers - Top risers and fallers at 11:00

FTSE 100 SABMiller 3670.00 +21.74% Reckitt Benckiser Group 5848.00 +2.79% Hargreaves Lansdown 1219.00 +2.61% Aberdeen Asset Management 327.80 +2.
16-Sep-2015 10:24 AM

ABInBev eyes SABMiller

SABMiller has responded to recent press speculation and confirmed that Anheuser-Busch InBev SA/NV ("ABInBev") intends to make a proposal to acquire SABMiller. Its shares have rose more than 20% to midday. No proposal has yet been received and t
16-Sep-2015 10:02 AM

Market Movers - Top risers and fallers between 09:00 and 10:00

Overall Market Graphene NanoChem 19.13 +2.03% Mosman Oil And Gas Limited Ord Npv 7.75 +1.57% Gulf Marine 116.38 +0.87% Rathbone Brothers 2186.00
16-Sep-2015 10:00 AM

Market Movers - Top risers and fallers at 10:00

FTSE 100 Aberdeen Asset Management 331.90 +3.62% SABMiller 3100.25 +2.84% Burberry Group 1444.00 +2.78% Hargreaves Lansdown 1220.00 +2.
16-Sep-2015 09:54 AM

Xchanging appoints new CEO

Xchanging announces the appointment of Craig Wilson as the new Chief Executive Officer. At 9:54am: (LON:XCH) Xchanging PLC share price was +0.75p at 93.25p Story provided by
16-Sep-2015 09:48 AM

Hummingbird encouraged by Liberia HEP report

Hummingbird Resources is 'highly encouraged' by a positive preliminary report from Knight Piesold Consulting for the proposed hydro-electric power plant in south-east Liberia - around 10km from Hummingbird's 4.2Moz Dugbe gold project. It
16-Sep-2015 09:25 AM

Haynes Publishing CEO to retire

Haynes Publishing Group chief executive Eric Oakley has given notice of his intention to retire from 31 May 2016 after 35 years with the company. At 9:25am: (LON:HYNS) Haynes Publishing Group PLC share price was 0p at 111.5p Story provided by Stock
16-Sep-2015 09:23 AM

CDC's sale

Copper Development Corporation has agreed to sell its wholly-owned CDC Philippines Holdings to 0999562 B.C. Ltd., a company incorporated in British Columbia, Canada, for $500,000 in cash. CDC Philippine's sole asset is its indirect 92.5% economic i
16-Sep-2015 09:17 AM

Eagle Eye revenues up 165%

Eagle Eye's group revenue increased by 165% to £4.9m in the year to the end of June. Of total revenue, £2.1 million was contributed by 12 months of revenue from the 2ergo acquisition which completed in the middle of April. Excluding 2ergo, organi
16-Sep-2015 09:03 AM

Saint-Gobain's Sika acquisition approved

Compagnie Saint-Gobain has welcomed the COMCO's decision which has unconditionally authorised Saint-Gobain's acquisition of control over Sika. This decision follows the favourable ruling handed down by the European Commission on 22 July as wel
16-Sep-2015 09:02 AM

Market Movers - Top risers and fallers between 08:00 and 09:00

Overall Market Nektan Ord 1p Di 150.00 +1.69% Lonmin 22.60 +1.16% Petroneft Resources 4.50 +1.12% Utilitywise 195.75
16-Sep-2015 09:01 AM

OXACO changes name to Cronin

OXACO has changed its name to Cronin Group. The name change was approved by shareholders on 10 September. The company's new website can be accessed at The company also announced that Michael Bretherton has been appointed co
16-Sep-2015 09:00 AM

Market Movers - Top risers and fallers at 09:00

FTSE 100 Burberry Group 1444.00 +2.78% SABMiller 3089.50 +2.49% TUI AG 1226.00 +2.08% Aberdeen Asset Management 326.90 +2.
16-Sep-2015 08:58 AM

Anpario adjusted earnings up

Anpario - the international producer and distributor of natural feed additives for animal health, hygiene and nutrition - posts pre-tax profits from continuing operations by 8% to £1.6m in the six months to the end of June. Adjusted earnings before int
16-Sep-2015 08:47 AM

Collagen Solutions supply deal with Histogenics

Collagen Solutions has announced a supply agreement with Histogenics, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space. The supply agreement will encompass additional collagen material sourc
16-Sep-2015 08:44 AM

Amur completes drilling on Flangovy block 1

Amur Minerals Corporation has completed drilling on the first of five distinct resource areas at the Flangovy area of the Kun-Manie production licence. Block 1 contains approximately 8.5 million ore tonnes of resource and approximately 32% of the contain
16-Sep-2015 08:29 AM

Deltex Medical losses rise

Deltex Medical Group posts an operating loss of £2.1m for the six months to the end of June - up from £1.5m last time. Consumable revenues were flat at £2,530,000. ODM probe revenues were £110,000 (4%) lower with increases of £132,000 (28%) from the

a d v e r t i s e m e n t